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Introduction
The human immunodeficiency virus (HIV) 
is a lymphotropic and neurotrophic retrovirus that 
belongs to the Lentiviridae subfamily, causing a slow 
and chronic infection [1], affecting several organs and 
systems. Among them, the central nervous system is 
frequently affected, causing delays in neurodevelopment 
that can be one of the first symptoms of the 
disease [1], [2], [3], [4], [5], [6]. Children with vertically 
transmitted HIV can develop rapid or slow progressive 
psychoneuromotor development deceleration, which can 
begin as soon as six months of age. Other children may 
have static encephalopathy [1], [2], [3], [4], [5], [6].
Abnormalities and neurocognitive development 
among HIV-infected children become very important 
since the HIV cases in children were first reported in 
1980 in the United States [1]. HIV causes serious cell 
damage due to symptoms of acquired immunodeficiency 
syndrome. One of the serious cell damage is found 
in the brain that manifested into neurocognitive 
development. Symptoms were found to vary from 
moderate to severe. Moderate symptoms include 
abnormal muscle tone, while severe symptoms include 
progressive developmental delay and loss of ability 
in the previous milestone [2]. HIV infection in children 
can cause brain damage in the form of neurocognitive 
disorders. Untreated HIV-infected children are 
associated with the development of cognitive deficits, 
motoric, language, and psychological impairments [3]. 
Early developmental delays in language and cognitive 
abilities can affect various functions in daily life. Early 
identification and intervention can prevent cognitive 
impairment and language [4]. The cause of the 
problems is unclear, whether the impact of HIV itself 
in decreasing the mitochondrial DNA as found in HIV 
cases using antiretroviral therapy. One of the early 
predictor factors of worsen symptom of HIV infection 
are CD4 count [5].
The Cognitive Adaptive Test/Clinical Linguistic 
and Auditory Milestone Scale (CAT/CLAMS) was 
designed for use by primary pediatric health-care 
providers to screen children for cognitive delay 
using minimal equipment in a shorter time (usually 
15–20 min) [4]. CAT/CLAMS has been demonstrated 
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in normal children as well as high-risk groups of 
developmental delayed children between 1 and 
36 months of age [7], [8]. This study aimed to assess the 
correlation of Capute score with CD4 count among HIV-
infected children in Sanglah Hospital, Bali, Indonesia.
Methods
This research was conducted in Sanglah 
Hospital Bali from December 2013 to May 2014. The 
subjects were collected by consecutive sampling until 
we reached the minimum number of samples. The 
cross-sectional analytic study was used to assess the 
correlation of Capute scores with CD4 count among HIV-
infected children. Capute scores consist of two tests Cat 
and Clams tests will be performed to get Capute scores, 
and CD4 count was assessed by flow cytometry and HIV 
status was obtained from serologic test that recorded in 
the medical record. The Capute scores then classified into 
normal (>85), suspect (75–85), and mental retardation 
(<75). Inclusion criteria in this study were 0–36 months 
HIV-infected children who visit Pediatrics Polyclinic, 
Sanglah Hospital and got assignment from the parent 
by informed consent. Subject and the subject’s parents 
refused to participate in the study, subjects with other 
comorbid diseases, and subject whom loss to follow-up 
will be excluded from the study.
Ethical consideration
Ethical clearance was obtained from the 
Department of Research Development of Sanglah 
Hospital, Faculty of Medicine, Udayana University.
Results
During the study, there were 68 samples 
as the HIV group and 68 samples were selected as 
the control group. The characteristics of the study 
subjects are shown in Table 1. Almost the HIV group 
was male 37 (54.5%), but in the control group found 
predominantly female subjects of 38 (55.9%). Both 
HIV and control group were almost in 12–24-month-
old 31 (48.4%) and 33 (51.6%). Almost the HIV group 
was in the asymptomatic stage. The status of milestone 
development in the two groups was almost within 
normal limits. Clinical manifestations that occur in the 
HIV group were mostly without complaint.
The result of the correlation test showed 
average of CD4 count was 29.85 cells/mm3, mean of 
DQ CAT scores was 90.95 ± 10.8, and mean of DQ 
CLAMS scores 89.22 ± 6.9.
Table 1: Characteristics of the subjects
Characteristics of the subjects Human immunodeficiency virus group 
n (%)
Control group 
n (%)
Gender
Male 37 (54.5) 30 (44.1)
Female 31 (45) 38 (55.9)
Age (months)
0–12 14 (45.2) 17 (54.8)
13–24 31 (48.4) 33 (51.6)
25–36 23 (56.1) 18 (43.9)
Stadium of infection
Asymptomatic 39 (57.4) 0 (0)
Mild 14 (20.6) 0 (0)
Moderate 13 (19.1) 0 (0)
Severe 2 (2.9) 0 (0)
Developmental state
Mental retardation 1 (1.5) 0 (0)
Delayed speech 2 (2.29) 0 (0)
Normal 40 (58.8) 64 (94.1)
Suspect 25 (36.8) 4 (5.9)
Clinical manifestations
GIT (diarrhea) 2 (2.9) 0 (0)
GIT (vomiting) 1 (1.5) 0 (0)
Acute respiratory infection 17 (25) 0 (0)
Hyperpigmentation on skin 1 (1.5) 0 (0)
No symptom 42 (61.8) 0 (0)
Wasting syndrome 5 (7.4) 0 (0)
GIT: Gastro Intestinal Tract.
We included all of CD4 count, DQ CAT, and DQ 
Clams scores in HIV-infected children to get mean then 
tested by Pearson’s correlation test. The result showed 
a positive correlation of CD4 count with DQ Cat and DQ 
Clams, as described in Table 2. It means CD4 count 
significantly correlated with Capute scores.
Table 2: Pearson’s correlation of CD4 with Capute score in 
human immunodeficiency virus-infected children
Variable Min. Max. Mean±SD r p
CD4 count 17.50 40.70 29.85 cells/mm3
DQ CAT scores 72.30 145.0 90.95±10.8 0.331 0.006
DQ CLAMS scores 71.50 110.0 89.22±6.9 0.307 0.011
CAT: Cognitive Adaptive Test, CLAMS: Clinical Linguistic and Auditory Milestone Scale.
As shown in Table 3, subjects with CD4 
<25 cells/mm3 tend to be mental retardation, delayed 
speech, and suspect for cognitive impairment. in the 
contrary subject with CD4 > 25 cell/mm3 there were no 
evidence of mental retardation or delayed speech, and 
almost in normal cognitive performance in the contrary.
Table 3: Cognitive state based on CD4 count
Category of CD4 
count
Cognitive state
Mental retardation delayed speech Normal Suspect
<25 cells/mm3 1 2 4 8
>25 cells/mm3 0 0 37 16
Total 1 2 41 24
Discussion
CD4 count was the easiest predictor factor of 
the degree of HIV symptoms, and this study showed 
its positive correlation with Capute score. In line with 
previous research obtained that there was a positive 
correlation between cognitive disorders with CD4 
levels [9], [10], [11]. Positive correlation also found 
between CAT scores and CD4 count (r = 0.418 and 
p = 0.01). Significant correlation also found between 
Clams scores with CD4 count (r = 0.529 and p = 0.01). 
These results indicate that the lower of CD4 count and 
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the lower CAT/Clams scores. CD4 plays importance 
role in cognitive function of HIV-infected children, 
subject with CD4 <25 cells/mm3 had lower cognitive 
performance than subject with CD4 > <25 cells/mm3. 
As described previously by Vanprapar et al., microglial 
cells in neuron play a role in cognitive performance of 
HIV person [2], [12], [13]. In contrary to a previous study 
by Igumbor et al., there were little or no associations 
between the biomedical markers (CD4 count and viral 
load) and cognitive indicators. However, the quality of 
life tended to increase with increase in the CD4 cell 
count [14], [15], [16], [17], [18], [19].
Conclusion
From this study, it can be concluded that 
Capute scores are significantly correlated with CD4 
count. The lower the CD4 count, the lower the cognitive 
score. Further study should be conducted to analyze 
the mechanism of HIV infection affect cognitive 
performance on HIV-infected children before early 
intervention to prevent cognitive impairment on HIV-
infected children.
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